Cancer vaccine

MYPI2025003497A0Undetermined Publication Date: 2021-04-18UNIV OF SOUTHAMPTON +1
0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025003497
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-10-18
Filing Date
2020-10-19
Publication Date
2021-04-18
Patent Text Reader

Abstract

The present invention relates to nucleic acid vaccines which encode at least a MAGED4B protein, for use in the treatment of cancer in particular. Synergistic combinations with other anti-cancer agents are described, particularly immune checkpoint inhibitors. The cancer vaccine may further comprise an immunologically active fragment to enhance the immune response, and an additional cancer antigen, such as FJX1. Particular combination therapies of interest include immunotherapies, radiotherapy, targeted therapies and chemotherapies. Fig. 1
Need to check novelty before this filing date? Find Prior Art